You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Direct Acting Antiviral

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV RAS Testing in Public Health Programs

Unknown status
  • Hepatitis C
  • +3 more
  • Direct Acting Antivirals
  • Chandigarh, India
  • +1 more
Jan 22, 2020

Possible Differences in HCC Course Depending on DAA Treatment

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Direct Acting Antivirals
  • Warsaw, Mazowieckie, Poland
    Medical University of Warsaw
May 11, 2022

Insulin Resistance, Hepatitis C Trial in Alexandria (Sofosbuvir 400 milligram, Daclatasvir 60 milligram, Ribavirin 400

Completed
  • Insulin Resistance
  • Hepatitis C
  • Sofosbuvir 400 milligram
  • +3 more
  • Alexandria, Egypt
    Faculty of Medicine
Jun 30, 2020

HIV, Hepatitis C, Cirrhosis Trial in United States (Harvoni)

Completed
Has Results
  • HIV
  • +2 more
  • San Francisco, California
  • +7 more
Jan 12, 2021

Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral

Recruiting
  • Coronary Artery Disease
  • +2 more
  • Direct-acting oral anticoagulation
  • Rozzano, Milan, Italy
  • +3 more
Mar 22, 2022

Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)

Not yet recruiting
  • Ptsd
  • White River Junction, Vermont
    White River Junction VAMC
Dec 12, 2022

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Ptsd Trial in White River Junction (Glecaprevir / Pibrentasvir Pill)

Not yet recruiting
  • Ptsd
  • Glecaprevir / Pibrentasvir Pill
  • White River Junction, Vermont
    White River Junction VAMC
Dec 12, 2022

Pulmonary Arterial Hypertension in Direct-Acting Antiviral

Completed
  • Pulmonary Artery Hypertension
  • Chronic Hepatitis c
  • transthoracic doppler-echocardiography (TTE)
  • Olten, Switzerland
    Kantonsspital Olten
Sep 19, 2019

Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment Trial in Cairo (evaluation of sofuspovir

Unknown status
  • Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment
  • evaluation of sofuspovir containing DAA regien expected insult on kidney
  • Cairo, Egypt
    Thabet Thabet Hospital For Internal Diseases
Feb 11, 2020

Chronic Hepatitis c Trial in Assiut, Assuit (Sofosbuvir , daclatasvir, Placebos)

Unknown status
  • Chronic Hepatitis c
  • Sofosbuvir , daclatasvir
  • Placebos
  • Assiut, Assuit, Egypt
  • +1 more
Sep 10, 2019

Egyptian Patients, HCV Treatment, Kidney Function Trial in Cairo (Sofosbuvir Oral Product)

Unknown status
  • Egyptian Patients, HCV Treatment, Kidney Function
  • Sofosbuvir Oral Product
  • Cairo, Egypt
    Thabet Thabet hospital
Nov 17, 2019

Frequency of Anxiety and Depression in Chronic Hepatitis C

Unknown status
  • Chronic Hepatitis c
  • Direct Acting Antivirals
  • (no location specified)
Jul 5, 2019

Heart Failure Trial in Los Angeles, Durham, Dallas (Epclusa)

Recruiting
  • Heart Failure
  • Los Angeles, California
  • +2 more
Jan 27, 2022

Safety of Direct-acting Antivirals in Patients With Hepatitis C

Completed
Has Results
  • Hepatitis C, Chronic
  • Direct Acting Antivirals
  • (no location specified)
Aug 5, 2019

Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral

Not yet recruiting
  • Subdural Hematoma
  • Atrial Fibrillation
  • Direct Acting Oral Anticoagulant starting at Day 30
  • Direct Acting Oral Anticoagulant starting at Day 90
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jul 26, 2022

End Stage Renal Disease Trial in United States (Epclusa)

Recruiting
  • End Stage Renal Disease
  • Birmingham, Alabama
  • +8 more
Feb 1, 2023

Hepatitis C Trial in Be'er Sheva, Petah Tikva (Direct acting anti-viral agents)

Completed
  • Hepatitis C
  • Direct acting anti-viral agents
  • Be'er Sheva, Israel
  • +1 more
Feb 17, 2021

Kidney Failure, Kidney Diseases, Hepatitis C Trial in Boston (glecaprevir/pibrentasvir tablets)

Withdrawn
  • Kidney Failure
  • +2 more
  • glecaprevir/pibrentasvir tablets
  • Boston, Massachusetts
    Massachusetts General Hospital
May 30, 2019

Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

Completed
  • Hepatitis B
    • Bethesda, Maryland
      National Institute of Diabetes and Digestive and Kidney Disorder
    May 29, 2019

    Hepatitis C, Chronic Trial in Japan (AL-335, Odalasvir (ODV), Simeprevir (SMV))

    Completed
    Has Results
    • Hepatitis C, Chronic
    • Amagasaki-shi, Japan
    • +13 more
    Sep 10, 2019

    HCV-TARGET- Hepatitis C Therapeutic Registry and Research

    Active, not recruiting
    • Hepatitis C
      • Phoenix, Arizona
      • +59 more
      Oct 5, 2022

      HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)

      Active, not recruiting
      Has Results
      • HIV Infections
      • CAB LA
      • +3 more
      • Phoenix, Arizona
      • +29 more
      Jan 22, 2023

      Hepatitis C Trial in Ottawa (ABT450r-ABT267-ABT333 +/- Ribavirin)

      Completed
      • Hepatitis C
      • ABT450r-ABT267-ABT333 +/- Ribavirin
      • Ottawa, Ontario, Canada
        The Ottawa Hospital, General Campus
      Aug 9, 2019

      Kidney Failure Trial in Loma Linda (Kidney Transplantation)

      Enrolling by invitation
      • Kidney Failure
      • Kidney Transplantation
      • Loma Linda, California
        Loma Linda University Health-Transplant Institute
      Nov 29, 2022